TEXERE
A bankruptcy procedure is open for TEXERE according to publications in the Belgian State Gazette. The 2024 annual accounts show equity of €520k and a net result of €-480k.
| Equity | €520k |
| Net result | €-480k |
| Staff (FTE) | 6.1 |
| Better than sector | 51% |
Fragile profile, watch health in particular.
Bankruptcy opened
A bankruptcy procedure is already open, a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 67.5% | 66.7% | |
| Net result | €-480k | €46k | |
| Equity | €520k | €79k | |
| Gross operating margin | €169k | €78k | |
| Staff costs | €553k | €21k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-407k |
| Net profit | €-480k |
| Cash flow | €-414k |
| Staff costs | €553k |
| Income taxes | €217 |
| Dividends | - |
| Total assets | €771k |
| Equity | €520k |
| Debt | €250k |
| of which ≤ 1y | €250k |
| of which > 1y | - |
| Working capital | €356k |
| Employees (FTE) | 6.1 |
| 2024 | |
|---|---|
| Current ratio | 2.42 |
| Quick ratio | 0.50 |
| Working capital ratio | 46.2% |
| Solvency | 67.5% |
| Debt / equity | 0.48 |
| Long-term debt ratio | - |
| Interest coverage | -54.42 |
| Gross margin | - |
| Net margin | - |
| ROA | -62.2% |
| ROE | -92.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €771k |
| Fixed assets | 21/28 | €165k |
| Intangible fixed assets | 21 | €14 |
| Tangible fixed assets | 22/27 | €165k |
| Current assets | 29/58 | €606k |
| Stocks & contracts in progress | 3 | €482k |
| Amounts receivable within one year | 40/41 | €28k |
| Cash & bank | 54/58 | €72k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €771k |
| Equity | 10/15 | €520k |
| Contributions / capital | 10/11 | €1.00M |
| Accumulated profits (losses) | 14 | €-480k |
| Amounts payable | 17/49 | €250k |
| Amounts payable within one year | 42/48 | €250k |
| Trade debts payable within one year | 44 | €98k |
| Income statement | ||
| Gross operating margin | 9900 | €169k |
| Operating result | 9901 | €-472k |
| Financial income | 75 | €51 |
| Financial charges | 65 | €7k |
| Result before taxes | 9903 | €-479k |
| Income taxes | 67/77 | €217 |
| Net result for the period | 9904 | €-480k |
| Result to be appropriated | 9905 | €-480k |
| Role | Name | Tenure | Source |
|---|---|---|---|
| Curator | KARL DE RIDDER RUE DU PARC,49, 6000 CHAR-
LEROI- .
Date provisoire de cessation de paiement : 29/06/2026 |
29-06-2026 → present | Belgian State Gazette |
| NACE primary | Human health(86910) |
| Legal form | Public limited company(014) |
| Incorporation | 02-02-2024 |
| Status | Active |
| Postal code | 6210 |
| First BS signal | 03-07-2026 |
| Latest BS signal | 03-07-2026 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52024B0182/00M003 | Wallonia | 5,078 m² | 1 · 686 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
29-08-2025 THERACELL CONSULTING resigns as director
- THERACELL CONSULTING, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "THERACELL CONSULTING",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2025-08-04",
"evidence_quote": "L\u0027assembl\u00E9e acte, \u00E0 dater de ce jour la d\u00E9mission de la SRL THERACELL CONSULTING de ses fonctions d\u0027administrateur de la soci\u00E9t\u00E9.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": "Delphine COGNEAU",
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-08-29",
"filing_date": "2025-08-21",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-08-04",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1005.576.333",
"name_full": "TEXERE",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Delphine COGNEAU",
"org_rep_person_name": null,
"person_role_at_subject": "Notaire associ\u00E9e"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}09-10-2024 Transaction in capital or shares
Technical details
{
"events": [],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-10-09",
"filing_date": "2024-10-07",
"act_kind_objet": "Objet de l\u0027acte :"
},
"decision": {
"body": null,
"act_date": null,
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1005.576.333",
"name_full": "TEXERE",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}05-07-2024 Capital increase of €750,000 to €750,000
- €0 → €750.000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 750000.0,
"delta_eur": 750000.0,
"before_eur": 0.0,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Luc LIEGEOIS",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "geld",
"n_shares_subscribed": 1500,
"contribution_amount_eur": 750000.0
}
],
"_arith_derived": "before",
"share_emission": {
"agio_eur": 250000.0,
"share_form": null,
"share_class": null,
"n_new_shares": 1500,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 500.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 250000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": 500000.0,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Gr\u00E9goire Michaux",
"firm_city": null,
"firm_name": null,
"office_city": "Beauvechain",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-07-05",
"filing_date": "2024-07-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-06-28",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "1005.576.333",
"name_full": "T4.0",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Exp\u00E9dition de l\u0027acte",
"Statuts coordonn\u00E9s"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "SRL THERACELL CONSULTING",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Ma\u00EEtre Karl DE RIDDER",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Luc LIEGEOIS",
"role": null,
"n_shares": 1500,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "DUFRANE Denis",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "LIEGEOIS Luc",
"role": null,
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 2000,
"class_name": "Gewone Aandelen",
"capital_share_eur": 1000000.0,
"voting_rights_per_share": 1.0
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | TEXERE |